To determine whether elevated levels of hemostatic and inflammatory markers [von Willebrand factor (vWF), fibrinogen, D-dimer, factor VII, factor VIII, PAI-1, tPA, beta-thromboglobulin (β-TG), CRP, and WBC count] are associated with increased peripheral arterial disease (PAD) prevalence, measured by low ABI, we studied 13,778 participants from the ARIC study in a cross-sectional analysis after adjustment for major cardiovascular risk factors. PAD was positively associated with fibrinogen, vWF, factor VIII, WBC count, D-dimer, β-TG, and CRP (p for trend <0.05) but not with the other markers. Adjusted odds ratios for the highest versus the lowest quartile of fibrinogen in men and women, respectively, were 3.49 (95% CI 1.68—7.26) and 2.44 (95% CI 1.58—3.77); for vWF 2.36 (95% CI 1.36—4.07) and 1.45 (95% CI 1.00—2.10); for factor VIII 2.31 (95% CI 1.36—3.94) and 1.68 (95% CI 1.14—2.48). In a smaller subset, the sex and risk factor adjusted odds ratio for the highest versus the lowest quartile of D-dimer was 2.70 (95% CI 1.56—4.65), for β-TG was 1.80 (95% CI 1.12—2.88), and for CRP was 1.57 (95% CI 0.84—2.95). Plasma levels of hemostatic and inflammatory markers are elevated in PAD, suggesting these processes are involved in the pathophysiology of PAD.
Newman AB, Sutton-Tyrell K., Rutan GH, Locher J., Kuller LHLower extremity arterial disease in elderly subjects with systolic hypertension . J Clin Epidemiol1991; 44: 15—20.
2.
Criqui MH, Denenberg JO, Langer RD, Fronek A.The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med1997; 2: 221—26.
3.
Meijer WT, Hoes AW, Rutgers D., Bots ML, Hofman A., Grobbee DEPeripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol1998; 18: 185—92.
4.
Fowkes FG, Housley E., Cawood EH, Macintyre CC, Ruckley CV, Prescott RJEdinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol1991; 20: 384—92.
5.
Criqui MH, Fronek A., Barrett-Connor E., Klauber MR, Gabriel S., Goodman D.The prevalence of peripheral arterial disease in a defined population . Circulation1985; 71: 510—15.
6.
Fowkes FGR.Epidemiology of peripheral vascular disease . Atherosclerosis1997; 131(suppl): S29—S31.
7.
Criqui MH, Langer RD, Froneck A. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med1992; 326: 381—86.
8.
Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol1996; 25: 1172—81.
9.
Newman AB, Shemanski L., Manolio TA et al. Ankle—arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol1999; 19: 538—45.
10.
Assman G., Cullen P., Heinrich J., Schulte H.Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Munster Heart Study (PROCAM). Prospective Cardiovascular Munster Study. Isr J Med Sci1996; 32: 364—70.
11.
Thompson SG , Kienast J., Pyke SDM , Haverkate F., van de Loo JCW for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris . N Engl J Med1995; 332: 635—41.
12.
Tracy RP, Arnold AM, Ettinger W., Fried L., Meilahn E., Savage P.The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study . Arterioscler Thromb Vasc Biol1999; 19: 1776—83.
13.
Folsom AR, Rosamond WD, Shahar E. et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation1999; 100: 736—42.
14.
Folsom AR, Wu KK, Rosamond WD, Sharrett A., Richey A., Chambless LEProspective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Circulation1997; 96: 1102—108.
15.
Folsom AR, Aleksic N., Park E., Salomaa V., Juneja H., Wu KKProspective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol2001; 21: 611—17.
16.
Meade TW, Mellows S., Brozovic M. et al. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet1986; ii: 533—37.
17.
Bogaty P., Poirier P., Simard S., Boyer L., Solymoss S., Dagenais GRBiological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation2001; 103: 3062—68.
18.
Lowe GD, Fowkes FG, Dawes J., Donnan PT, Lennie SE, Housley E.Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation1993; 87: 1915—20.
19.
Newman AB, Siscovick DS, Manolio TA et al. Ankle—arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation1993 ; 88: 837—45.
20.
Tzoulaki I. , Murray GD, Price JF et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: The Edinburgh Artery Study. Am J Epidemiol2005; 163: 334—41.
21.
Allison MA, Criqui MH, McClelland RL et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol2006; 48: 1190—97.
22.
McDermott MM , Guralnik JM, Corsi A. et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J2005; 150: 276—81.
23.
Ridker PM, Stampfer MJ, Rifai N.Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA2001; 285: 2481—85.
24.
Philipp CS, Cisar LA, Kim HC, Wilson AC, Saidi P., Kostis JBAssociation of hemostatic factors with peripheral vascular disease . Am Heart J1997; 134: 978—84.
25.
Blann AD, Seigneur M., Steiner M., Boisseau MR, McCollum CNCirculating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest1997; 27: 916—21.
26.
McDermott MM , Green D., Greenland P. et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index . Am J Cardiol2003; 92: 194—99.
27.
Aboyans V., Criqui MH, Denenberg JO et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation2006 ; 113: 2623—29.
28.
McDermott MM , Ferrucci L., Liu K. et al. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc2005; 53: 1688—96.
29.
McDermott MM , Greenland P., Green D. et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation2003; 107: 3191—98.
30.
The ARIC Investigators.The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives . Am J Epidemiol1989; 129: 687—702.
31.
Mundt KA, Chambless LE, Burnham CB, Heiss G.Measuring ankle systolic blood pressure: validation of the Dinamap 1846 SX . Angiology1992; 43: 555—66.
32.
Weatherley BD, Nelson JJ, Heiss G. et al. The association of the ankle—brachial index with incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, 1987—2001. BMC Cardiovasc Disord2007; 7: 3.
33.
Aboyans V., Criqui MH, McClelland RL et al. Intrinsic contribution of gender and ethnicity to normal ankle—brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg2007; 45: 319—27.
34.
Papp AC, Hatzakis H., Bracey AW, Wu KKARIC Hemostasis Study-1. Development of a blood collection and processing system suitable for multicentric studies. Thromb Haemost1989; 61: 15—19.
35.
Chambless L. , McMahon R., Wu K., Folsom A., Finch A., Shin YLShort-term intraindividual variability in hemostasis factors. The ARIC Study. Ann Epidemiol1992; 2: 723—33.
36.
Friedewald WT, Levy RI, Fredrickson DSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge . Clin Chem1972; 18: 499—502.
37.
ARIC Protocol Manual 9.Hemostasis determinations. Chapel Hill, NC: National Heart Lung and Blood Institute of the National Institutes of Health Collaborative Studies Coordinating Center, University of North Carolina , 1987.
38.
Nguyen ND, Ghaddar H., Stinson V., Chambless LE, Wu K.ARIC Hemostasis Study-IV. Intraindividual variability and reliability of hemostasis factors. The Atherosclerosis Risk in Communities (ARIC) study . Thromb Haemost1995; 73: 256—60.
39.
Folsom AR, Aleksic N., Catellier D., Juneja HS, Wu KKC-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities study. Am Heart J2002 ; 144: 233—38.
40.
Fowkes FGR , Lowe GDO , Housley E. et al. Cross-linked fibrin degradation products and the progression of peripheral arterial disease and risk of coronary heart disease. Lancet1993; 342: 84—86.
41.
Smith FB, Lee AJ, Rumley A., Fowkes FG, Lowe GDTissue plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis1995; 115: 35—43.
42.
Mackiewicz A., Speroff T., Ganapathi MK, Kushner I.Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol1991; 146: 3032—37.
43.
Hurlimann J. , Thorbecke GJ, Hochwald GMThe liver as the site of C-reactive protein formation. J Exp Med1966; 123: 365—78.
44.
Ridker PM, Cushman M., Stampfer MJ, Tracy RP, Hennekens CHPlasma concentration of C-reactive protein and risk of developing peripheral arterial disease. Circulation1998 ; 97: 425—28.
